Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

30%

3 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
3(33.3%)
Phase 1
3(33.3%)
Phase 2
2(22.2%)
N/A
1(11.1%)
9Total
Phase 3(3)
Phase 1(3)
Phase 2(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT04027296Completed

Development and Validation of the GLORI-COPD Score

Role: collaborator

NCT02014727Phase 1Completed

Safety and Immunogenicity of Recombinant Pichia Pastoris AMA1-DiCo Candidate Malaria Vaccine With GLA-SE and Alhydrogel ® as Adjuvant in Healthy Malaria Non-Exposed European and Malaria Exposed African Adults

Role: collaborator

NCT02658253Phase 1Completed

Trial to Evaluate the Safety and Immunogenicity of a Placental Malaria Vaccine Candidate (PRIMVAC ) in Healthy Adults

Role: collaborator

NCT03069703Phase 2Completed

Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy

Role: collaborator

NCT04166656Phase 3Recruiting

Research Trial Assessing the Immunogenicity and Safety of Three Meningococcal B Vaccine Strategies Among Patients With Asplenia.

Role: collaborator

NCT03424460Not ApplicableCompleted

Venous Thromboembolism in Myotonic Dystrophy Type 1

Role: collaborator

NCT04844775Phase 1Completed

A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected Adults

Role: collaborator

NCT03873727Phase 2Unknown

Revaccination With PPS23 Boosted or Not by PCV13 in Splenectomised Patients.

Role: collaborator

NCT02849899Phase 3Unknown

Prevention of Diabetes After Transplantation by Vildagliptin in the Early Post-transplant Period

Role: collaborator

NCT03513822Phase 3Unknown

Ketamine's Efficiency in the Treatment of Chronic Pain: Kynurenin Pathway

Role: collaborator

All 10 trials loaded